Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Instructions to Really Oversee Unsold SUVs in the Auto Business - 2Understanding Preschool Projects: Cultivating Abilities and Advancement
- 3FDA approves Wegovy pill for weight loss: What to know
- 4IDF destroys Hezbollah rocket launcher used in large rocket salvo towards Haifa, Galilee
- 5Figure out How to Analyze Medical attendant Compensation Patterns Across Different Specializations
- Book excerpt: "Eat Your Ice Cream" by Ezekiel J. Emanuel, M.D.
- What are the health benefits of whole milk for kids?
- The Eastern Bongo, Kenya’s Rare Forest Antelope on the Brink
- Consumer experts: German petrol hikes rule won't bring down prices
- Mojtaba Khamenei unconscious in Qom, not actually running Iran
- Astronauts' brains change shape and position after time in space, study finds
- What's the new 'Knives Out' mystery about? Everything to know about 'Wake Up Dead Man,' including who's in the cast and what the reviews say.
- The Tradition of Stone: A Gander at Notable Structures Through the Ages
- 5 Great Home Remodel Administrations With Green Arrangements In 2024
